Reply to "Comments and opinions regarding 'A randomized trial of open lung protective ventilation compared to conventional mechanical ventilation in deceased organ donors' by Ware LB et al." [0.03%]
对“WareLB等关于‘器官捐献者保护性通气与常规机械通气的随机对照试验’的意见和评价”的回复
Lorraine B Ware,Tatsuki Koyama,Ciara M Shaver et al.
Lorraine B Ware et al.
Comments and opinions regarding "A randomized trial of open lung protective ventilation compared to conventional mechanical ventilation in deceased organ donors" by Ware LB et al [0.03%]
关于Ware LB等人发表的“开放肺保护性通气与常规机械通气比较的随机试验”的评论及观点
Parth Aphale,Himanshu Shekhar,Shashank Dokania
Parth Aphale
Comment on "A randomized trial of open lung protective ventilation compared to conventional mechanical ventilation in deceased organ donors" [0.03%]
对“开放式保护性通气与常规机械通气随机对照研究”的点评
Guanyu Yang,Qinjun Chu
Guanyu Yang
Reassessing the impact of ex vivo heart perfusion in donation after brain death heart transplantation [0.03%]
体外心肺循环在脑死亡供者心脏移植中的影响评估研究
Yeahwa Hong,David J Kaczorowski
Yeahwa Hong
Navigating increasing donor age and extended preservation times with machine perfusion [0.03%]
机器灌注在供者年龄增大和保存时间延长情况下的应用
Shivank Madan,Omar Saeed,Daniel J Goldstein et al.
Shivank Madan et al.
Don Hayes,Nicholas Avdimiretz,Rossa Brugha et al.
Don Hayes et al.
Evaluating oral selexipag in PAH: Insights on survival, safety and dosing patterns from the complete observation period of GRIPHON and its open-label extension [0.03%]
口服塞莱西帕治疗肺动脉高压的疗效评价：来自GRIPHON完整观察期及其开放标签延长期的生存、安全性及剂量使用情况的见解
Vallerie V McLaughlin,Luke Howard,Jean Elwing et al.
Vallerie V McLaughlin et al.
Background: Selexipag, an oral prostacyclin receptor agonist, significantly reduced morbidity/mortality risk versus placebo for patients with pulmonary arterial hypertension (PAH) in GRIPHON. Five-year survival estimates ...
Molecular biopsy features associated with baseline lung allograft dysfunction in a multicenter international cohort [0.03%]
多中心国际队列中与基线肺移植物功能障碍相关的分子活检特征
Martina Mackova,Patrick Gauthier,Jessica Chang et al.
Martina Mackova et al.
Background: Baseline lung allograft dysfunction (BLAD) is a state of abnormally low peak post-transplant lung function, but the mechanisms are poorly understood. In this study, we examined transbronchial biopsy (TBB) gene...
Pulmonary Artery Fresh Floating Thrombus in Patients with Chronic Thromboembolic Pulmonary Hypertension on Low-Dose Direct Oral Anticoagulants: A Single-Center Angiographic Observational Study [0.03%]
慢性血栓栓塞性肺动脉高压患者小剂量直接口服抗凝治疗的肺动脉新发游离血栓：一项单中心导管室观察研究
Takeshi Suetomi,Hiroto Shimokawahara,Keiichiro Kuronuma et al.
Takeshi Suetomi et al.
Direct oral anticoagulants (DOACs) are widely used in chronic thromboembolic pulmonary hypertension (CTEPH); however, the safety and efficacy of reduced-dose regimens remain unclear. We retrospectively analyzed 721 follow-up selective pulmo...
Not for the Faint of Heart-and Yet: Donation after Circulatory Death Simultaneous Heart-Kidney Transplantation Delivers [0.03%]
勇往直前：心源性死亡后公民捐献心脏-肾脏联合移植临床报告
Maria Francesca Scuppa,Guillaume Coutance
Maria Francesca Scuppa